Saba Capital Files 13D for Gabelli Healthcare & WellnessRx Trust
Ticker: GRX · Form: SC 13D · Filed: Jul 10, 2024 · CIK: 1391437
| Field | Detail |
|---|---|
| Company | Gabelli Healthcare & Wellnessrx Trust (GRX) |
| Form Type | SC 13D |
| Filed Date | Jul 10, 2024 |
| Risk Level | medium |
| Pages | 8 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.001, $15,506,926 |
| Sentiment | neutral |
Sentiment: neutral
Topics: activism, ownership-change, filing
TL;DR
**SABA CAPITAL TAKES STAKE IN GABELLI HEALTHCARE!**
AI Summary
Saba Capital Management, L.P. has filed a Schedule 13D on July 10, 2024, indicating a change in beneficial ownership of Gabelli Healthcare & WellnessRx Trust. The filing does not specify the exact number of shares or percentage owned, but it signifies Saba Capital's active interest in the company.
Why It Matters
This filing signals increased investor scrutiny or potential activism by Saba Capital Management, which could lead to changes in the company's strategy or governance.
Risk Assessment
Risk Level: medium — Schedule 13D filings often precede activist campaigns or significant strategic shifts, introducing uncertainty for investors.
Key Players & Entities
- Saba Capital Management, L.P. (company) — Filing entity
- Gabelli Healthcare & WellnessRx Trust (company) — Subject company
- Michael D'Angelo (person) — Contact person for Saba Capital
FAQ
What is the exact percentage of Gabelli Healthcare & WellnessRx Trust shares beneficially owned by Saba Capital Management, L.P. as of July 10, 2024?
The provided filing excerpt does not specify the exact percentage or number of shares beneficially owned by Saba Capital Management, L.P. as of July 10, 2024.
What is the CUSIP number for Gabelli Healthcare & WellnessRx Trust's common shares?
The CUSIP number for Gabelli Healthcare & WellnessRx Trust's common shares is 36246K103.
Who is the authorized contact person for Saba Capital Management, L.P. regarding this filing?
Michael D'Angelo is the person authorized to receive communications for Saba Capital Management, L.P. at 405 Lexington Avenue, 58th Floor, New York, NY 10174, with a telephone number of (212) 542-4635.
When was the Gabelli Healthcare & WellnessRx Trust formerly known as Gabelli Global Healthcare & WellnessRx Trust?
The company's name changed from Gabelli Global Healthcare & WellnessRx Trust to Gabelli Healthcare & WellnessRx Trust on February 27, 2007.
What is the business address and phone number for Gabelli Healthcare & WellnessRx Trust?
The business address for Gabelli Healthcare & WellnessRx Trust is One Corporate Center, Rye, NY 10580-1422, and the business phone number is 914-921-5100.
Filing Stats: 2,502 words · 10 min read · ~8 pages · Grade level 11.6 · Accepted 2024-07-10 18:27:24
Key Financial Figures
- $0.001 — rust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securiti
- $15,506,926 — ported herein. A total of approximately $15,506,926 was paid to acquire the Common Shares r
Filing Documents
- formsc13d.htm (SC 13D) — 101KB
- exhibit1.htm (EX-1) — 5KB
- 0001062993-24-013647.txt ( ) — 107KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: July 10, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 36246K103 SCHEDULE 13D Page 10 of 10 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital during the past sixty days. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 5/10/2024 Buy 2,710 9.74 5/13/2024 Buy 21,869 9.76 5/14/2024 Buy 58,790 9.77 5/15/2024 Buy 29,093 9.87 5/16/2024 Buy 18,792 9.88 5/17/2024 Buy 20,501 9.85 5/20/2024 Buy 5,918 9.78 5/21/2024 Buy 28,610 9.80 5/22/2024 Buy 22,948 9.78 5/23/2024 Buy 1,784 9.70 5/24/2024 Buy 1,843 9.63 5/29/2024 Buy 10,734 9.38 5/30/2024 Buy 4,900 9.41 5/31/2024 Buy 4,081 9.53 6/3/2024 Buy 1,710 9.70 6/4/2024 Buy 26,742 9.75 6/5/2024 Buy 10,137 9.87 6/6/2024 Buy 27,075 9.92 6/7/2024 Buy 24,623 9.96 6/10/2024 Buy 30,733 9.88 6/11/2024 Buy 37,884 9.81 6/12/2024 Buy 47,593 9.82 6/13/2024 Buy 49,502 9.62 6/14/2024 Buy 26,053 9.51 6/17/2024 Buy 12,270 9.52 6/18/2024 Buy 5,449 9.52 6/20/2024 Buy 2,349 9.53 6/21/2024 Buy 27,959 9.59 6/25/2024 Buy 38,741 9.62 6/26/2024 Buy 23,